A nationwide recall has been announced for Xanax, one of the most widely used anxiety medications, due to potential quality issues affecting specific lots. The FDA has classified this recall as Class II, indicating a risk level that necessitates patient awareness. Millions of users are advised to check their prescriptions, as the recall stems from concerns surrounding dissolution failures and possible dangerous dosing errors. The affected lot includes Xanax XR, with patients urged to verify if their medications are impacted. This alert raises significant concern among users and healthcare professionals regarding the safety of this popular drug.